In bioproven GC individuals, the HEYL mRNA and serum CA19‐9 levels (kU/L) were used to construct a ROC curve to fully calculate the predicting accuracy for GC stage, OS, and tumor recurrence estimation. The gene discussed is HEYL; the disease is neoplasm.